Child Development and, Surveillance, Research and Prevention

 

This funding supports State health agencies, universities, and public and private nonprofit organizations in planning, implementing, coordinating, or evaluating programs related to promoting optimal child health and development outcomes of all children by the detection, prevention, and management of factors that may lead to developmental delays or disorders, or increased morbidity, and by promoting optimal developmental practices within families and other systems that interact with youth. Programs may include the following activities: (1)conducting epidemiologic research or surveillance in the area of child development, developmental disabilities, children? mental health or neurobehavioral disorders such as Attention-Deficit/Hyperactivity Disorder (ADHD) and Tourette syndrome (TS) and related comorbidities; (2)support the improvement of infant and child health and developmental outcomes by establishing resources for both professionals and the public regarding what is known the impact, epidemiology, and interventions for child development, ADHD and TS and related comorbidities;(3) providing a national, State or local platform in the area of child development, developmental disabilities, children?s mental health and neurobehavioral disorders prevention that focuses on improving early identification of and intervention for children with ADHD, TS, and other co-occurring conditions, so children and families can receive the services and support they need;(4) conducting etiologic studies of child development, children?s mental health, and neurobehavioral disorders such as ADHD and TS using population based approaches to enhance existing research or surveillance programs to better address research questions, monitor changes in prevalence and contributing factors, and inform policy and program activities;(5) employing epidemiological methods to set priorities, build capacity and direct health promotion interventions for persons with or at risk for developmental delays, developmental disabilities, mental disorders or neurobehavioral disorders; (6) Conduct population based research that describes comorbidities and associated burden of ADHD and TS disseminating data and health information; (7)employing strategies to reduce racial/ethnic disparities in child development and in the identification of ADHD and TS and related comorbid conditions; (8) Fund and support a National Public Health Practice and Resource Center for Attention-Deficit/Hyperactivity Disorder; (9) Fund and Support a National Public Health Practice and Resource Center for Tourette Syndrome;(10) Fund and support projects that promote optional child development and health for all children.

Deleted 03/27/2024 (Archived.) 93.312 Centers For Disease Control and Prevention, Department of Health and Human Services B - Project Grants Not applicable. Sections 317 (k) (2) and 317 (c) of the Public Health Service Act [42 U.S.C. Sections 247b (k) (2) and 247b-4 as amended. N/A In addition to the eligible applicants, other groups who will receive benefits from the program include persons with or at-risk for developmental delays, developmental disabilities, mental disorders, or neurobehavioral disorders such as Attention-Deficit/Hyperactivity Disorder, Tourette syndrome and the conditions that co-occur with them; family members of persons with or at-risk for developmental delays, developmental disabilities, mental disorders, or neurobehavioral disorders such as Attention-Deficit/Hyperactivity Disorder, Tourette syndrome and the conditions that co-occur with them; minority populations, including Spanish speaking populations, infants, children, youth, adults; Federally Recognized Indian Tribal Governments; individual and families; educators, health care professionals, Private nonprofit institution/organizations and others. Not applicable. Preapplication coordination is not applicable. 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. OMB Circular A-102 applies to this program. OMB Circular No. A-110 applies to this program. To apply for this Notice of Funding Opportunity, use application form PHS389 (OMB number 0925-0001 rev. 5/2001). Forms and instructions are available in an interactive format on the Grants.gov website. This program is subject to the provisions set forth in 45 CFR 92, for State and Local governments and OMB Circular No. A-110 for nonprofit organizations. After review and approval, a Notice of Award from the CDC Office of Grant Services (OGS) is prepared and signed by an authorized Grants Management Officer (GMO), and mailed to the recipient officer identified in the application, along with appropriate notification to the public. The initial award provides funds for the first budget period (usually 12 month) and Notice of Award indicates support recommended for the remainder of the project period, allocation of Federal funds by budget categories, and special conditions, if any. Cooperative Agreement competitive and single eligibility awards are determined by an internal objective committee review process at CDC. Research project grant competitive awardees are determined by an external peer review. At such times, awards will be based on evaluation criteria set forth in the respective Program Announcement, the availability of funds, and such other significant factors as deemed necessary and appropriate by CDC. The notice of award will indicate financial support for the first budget year, allocations of Federal funds by budget category, and special conditions if any. Contact the headquarters or regional location, as appropriate for application deadlines From 90 to 120 days. Not applicable. Project periods are from 1-5 years with 12-month budget periods. Applications must be obtained from Grants.gov. Throughout project periods, CDC's commitment to continuation of awards will be conditioned on the availability of funds and evidence of satisfactory progress by recipient as documented in the required reports. If additional support is desired to continue a project beyond the approved project period, an application for competing continuation must be submitted for review in the same manner as a new application. Projects are renewable for periods of 1 to 4 years. In general, applications are reviewed on the basis of scientific and technical merit, with attention given to such areas as (1) the degree to which the applicant satisfies the essential requirements and possesses other desired characteristics, such as depth, breadth, and merit of overall application relative to the types of projects proposed; (2) clarity of purpose and overall qualifications, adequacy and appropriateness of personnel to accomplish proposed prevention research projects and demonstration projects, and the nation's health priorities and needs; (3) ability to generalize, translate and disseminate to State or local health departments, national regional, and local public health agencies and organizations; are reviewed based on evaluation criteria explicit in the respective Program Announcements. Applications must address demonstrated program need, the magnitude of the problem, the management work plan, collaborative associations, and the approach toward setting and meeting overall project objectives and time frames. These future competitive applications would also be evaluated on the capacity of the applicant to demonstrate effective collaborations with other agencies and data sources critical to preventing secondary conditions, identifying and addressing health promotion needs for persons with Attention-Deficit/Hyperactivity Disorder (ADHD) and Tourette Syndrome (TS), denoting the capacity of the project to address minority and low income populations, Spanish speaking populations, co-occurring conditions, and offering sound proposals that reflect the understanding of the epidemiologic and surveillance research. Funds may be used to strengthen, expand, build upon or enhance epidemiologic research, surveillance, health promotion, education, and prevention/intervention activities that contribute to the mission and activities of the National Center on Birth Defects and Development and Disabilities, Division of Human Development and Disabilities. Funds may be used to improve and strengthen State and local public health infrastructure by providing technical assistance to other appropriate health agencies organizations, special groups or coalitions. Funds may be used to support capacity building, program planning, development, implementation, evaluation, and surveillance for optimal child health and development outcomes, developmental disabilities, children’s mental health, and neurobehavioral disorders including Attention-Deficit/Hyperactivity Disorder, Tourette syndrome, and other co-occurring conditions. Projects may include health promotion, education and training, prevention and intervention of Attention-Deficit/Hyperactivity Disorder and Tourette syndrome. Funds may also be used to coordinate and the dissemination of prevention information to the general public, target populations, state, and local agencies, and public and private sector organizations in the United States. Funds may not be used for advocacy initiatives. Funds May not be used for construction Performance Reports: The National Center for Birth Defects and Development Disabilities may propose on-site meetings, off-site or other processes for the exchange of information on progress toward objects of collaborative activities. Not applicable. There is a 3-year record retention requirement, records shall be retained beyond the 3-year period if final audit has not been done or findings resolved. Property records must be retained in accordance with the HHS Grants Policy Statement requirements Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. Assistance is available for 12-month budget periods within project periods ranging from 1 to 5 years. After awards are issued, funds are released in accordance with the payment procedures established by the grantee institution with DHHS, which may be an Electronic Transfer System or a Monthly Cost Request System. Method of awarding/releasing assistance: Quarterly. None/Not specified. Jennifer Kaminski
1600 Clifton Rd, NE MS-88
Atlanta, GA 30033 US
anu1@cdc.gov
Phone: 404-498-4159 75-0958-1-1-550 (Cooperative Agreements) FY 18$1,750,000.00; FY 19 est $1,750,000.00; FY 20 est $1,750,000.00; FY 17$1,750,000.00; FY 16$1,750,000.00; - The FY19/20 range is dependent upon funding availability. Awards amounts may range from $200,000 to $1,000,000. Not applicable. Not applicable.